Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial Presenter: Jeffrey Popma June 12, 2013
Presentation TVT 2013 The "Essential Primer" on Surgical Risk Scores: Key Take-home Messages Presenter: Todd Dewey June 12, 2013
Presentation TVT 2013 Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights Presenter: Philip Green June 12, 2013
Presentation TVT 2013 Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve Presenter: Petra Poliacikova June 12, 2013
Presentation TVT 2013 Not So Fast! Current Suture-Based Transfemoral Closure Devices Are More Than Adequate: The Vancouver Experience Presenter: David Wood June 12, 2013
Presentation TVT 2013 Vascular Complications: PARTNER Outcomes and Review of the Literature Presenter: Philippe Généreux June 12, 2013
Presentation Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI Presenter: M. Lamberts June 12, 2013
Presentation TVT 2013 How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union? Presenter: A. Pieter Kappetein June 12, 2013